Stay updated on MGCD516 Study in Advanced Cancer Clinical Trial
Sign up to get notified when there's something new on the MGCD516 Study in Advanced Cancer Clinical Trial page.

Latest updates to the MGCD516 Study in Advanced Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page has undergone significant updates, including the removal of detailed information about the drug MGCD516 and its clinical study, while adding a new version number and the name of the study director, Richard Chao, MD.SummaryDifference18%
- Check17 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check24 days agoNo Change Detected
- Check60 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check75 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check82 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check96 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
Stay in the know with updates to MGCD516 Study in Advanced Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MGCD516 Study in Advanced Cancer Clinical Trial page.